Vir Biotechnology, Inc. (VIR) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	303.2M	68.6M	74.2M	86.2M	1.6B
Cost of Revenue	11.5M	11.7M	15.4M	22.2M	161.8M
Gross Profit	291.7M	56.9M	58.8M	64.0M	1.5B
Operating Expenses
R&D Expense	471.8M	432.8M	463.2M	550.9M	467.9M
SG&A Expense	99.4M	92.1M	119.0M	174.0M	153.1M
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	571.2M	524.9M	582.2M	725.0M	620.9M
Cost and Expenses	582.7M	536.6M	597.6M	747.2M	782.7M
Operating Income (EBIT)	(279.5M)	(468.0M)	(523.4M)	(661.0M)	833.1M
Non-Operating
Interest Income	33.3M	40.2M	71.8M	87.0M	28.1M
Interest Expense	—	—	—	—	—
Net Interest Income	33.3M	40.2M	71.8M	87.0M	28.1M
Other Non-Op Income/Expense	28.2M	30.3M	316.0K	32.8M	(78.8M)
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	(251.3M)	(437.8M)	(523.1M)	(628.2M)	754.3M
Income Tax Expense	380.0K	217.0K	(1.1M)	(13.1M)	238.4M
Bottom Line
Net Income	(251.7M)	(438.0M)	(522.0M)	(615.1M)	515.8M
Earnings from Cont. Ops	(251.7M)	(438.0M)	(522.0M)	(615.1M)	515.8M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(251.7M)	(438.0M)	(522.0M)	(615.1M)	515.8M
Per Share
Basic EPS	($1.85)	($3.16)	($3.83)	($4.59)	$3.89
Diluted EPS	($1.86)	($3.16)	($3.83)	($4.59)	$3.83
Revenue Per Share	$1.81	$0.49	$0.54	$0.64	$12.18
Shares
Basic Shares Outstanding	167.7M	138.5M	136.2M	134.1M	132.6M
Diluted Shares Outstanding	168.9M	138.5M	136.2M	134.1M	134.8M
Profitability Metrics
EBITDA	(268.0M)	(456.3M)	(508.9M)	(641.6M)	848.6M
D&A	11.5M	11.7M	14.6M	19.5M	15.5M
EBIT	(279.5M)	(468.0M)	(523.4M)	(661.0M)	833.1M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026